<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">28716890</PMID>
      <DateCompleted>
        <Year>2019</Year>
        <Month>10</Month>
        <Day>23</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2020</Year>
        <Month>07</Month>
        <Day>01</Day>
      </DateRevised>
      <Article PubModel="Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1943-0264</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>10</Volume>
            <Issue>7</Issue>
            <PubDate>
              <Year>2018</Year>
              <Month>Jul</Month>
              <Day>02</Day>
            </PubDate>
          </JournalIssue>
          <Title>Cold Spring Harbor perspectives in biology</Title>
          <ISOAbbreviation>Cold Spring Harb Perspect Biol</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Negative Regulation of Cytokine Signaling in Immunity.</ArticleTitle>
        <ELocationID EIdType="pii" ValidYN="Y">a028571</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.1101/cshperspect.a028571</ELocationID>
        <Abstract>
          <AbstractText>Cytokines are key modulators of immunity. Most cytokines use the Janus kinase and signal transducers and activators of transcription (JAK-STAT) pathway to promote gene transcriptional regulation, but their signals must be attenuated by multiple mechanisms. These include the suppressors of cytokine signaling (SOCS) family of proteins, which represent a main negative regulation mechanism for the JAK-STAT pathway. Cytokine-inducible Src homology 2 (SH2)-containing protein (CIS), SOCS1, and SOCS3 proteins regulate cytokine signals that control the polarization of CD4<sup>+</sup> T cells and the maturation of CD8<sup>+</sup> T cells. SOCS proteins also regulate innate immune cells and are involved in tumorigenesis. This review summarizes recent progress on CIS, SOCS1, and SOCS3 in T cells and tumor immunity.</AbstractText>
          <CopyrightInformation>Copyright © 2018 Cold Spring Harbor Laboratory Press; all rights reserved.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Yoshimura</LastName>
            <ForeName>Akihiko</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Microbiology and Immunology, Keio University School of Medicine, Shinjuku-ku, Tokyo 160-8582, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ito</LastName>
            <ForeName>Minako</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Microbiology and Immunology, Keio University School of Medicine, Shinjuku-ku, Tokyo 160-8582, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Chikuma</LastName>
            <ForeName>Shunsuke</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Microbiology and Immunology, Keio University School of Medicine, Shinjuku-ku, Tokyo 160-8582, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Akanuma</LastName>
            <ForeName>Takashi</ForeName>
            <Initials>T</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Microbiology and Immunology, Keio University School of Medicine, Shinjuku-ku, Tokyo 160-8582, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Nakatsukasa</LastName>
            <ForeName>Hiroko</ForeName>
            <Initials>H</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Microbiology and Immunology, Keio University School of Medicine, Shinjuku-ku, Tokyo 160-8582, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
          <PublicationType UI="D016454">Review</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2018</Year>
          <Month>07</Month>
          <Day>02</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Cold Spring Harb Perspect Biol</MedlineTA>
        <NlmUniqueID>101513680</NlmUniqueID>
        <ISSNLinking>1943-0264</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D016207">Cytokines</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D016207" MajorTopicYN="N">Cytokines</DescriptorName>
          <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
          <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005786" MajorTopicYN="N">Gene Expression Regulation</DescriptorName>
          <QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D015398" MajorTopicYN="N">Signal Transduction</DescriptorName>
          <QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2017</Year>
          <Month>7</Month>
          <Day>19</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2019</Year>
          <Month>10</Month>
          <Day>24</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2017</Year>
          <Month>7</Month>
          <Day>19</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>epublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">28716890</ArticleId>
        <ArticleId IdType="pmc">PMC6028070</ArticleId>
        <ArticleId IdType="doi">10.1101/cshperspect.a028571</ArticleId>
        <ArticleId IdType="pii">cshperspect.a028571</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Ahmed CM, Larkin J IIII, Johnson HM. 2015. 
SOCS1 mimetics and antagonists: A complementary approach to positive and negative regulation of immune function. Front Immunol
6: 183.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4404822</ArticleId>
            <ArticleId IdType="pubmed">25954276</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Al Muftah WA, Al-Shafai M, Zaghlool SB, Visconti A, Tsai PC, Kumar P, Spector T, Bell J, Falchi M, Suhre K. 2016. 
Epigenetic associations of type 2 diabetes and BMI in an Arab population. Clin Epigenetics
8: 13.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4730771</ArticleId>
            <ArticleId IdType="pubmed">26823690</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Aman MJ, Migone TS, Sasaki A, Ascherman DP, Zhu M, Soldaini E, Imada K, Miyajima A, Yoshimura A, Leonard WJ. 1999. 
CIS associates with the interleukin-2 receptor β chain and inhibits interleukin-2-dependent signaling. J Biol Chem
274: 30266–30272.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10514520</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Asselbergs FW, Guo YR, van Iperen EPA, Sivapalaratnam S, Tragante V, Lanktree MB, Lange LA, Almoguera B, Appelman YE, Barnard J, et al.
2012. 
Large-scale gene-centric meta-analysis across 32 studies identifies multiple lipid loci. Am J Hum Genet
91: 823–838.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3487124</ArticleId>
            <ArticleId IdType="pubmed">23063622</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Babon JJ, Kershaw NJ, Murphy JM, Varghese LN, Laktyushin A, Young SN, Lucet IS, Norton RS, Nicola NA. 2012. 
Suppression of cytokine signaling by SOCS3: Characterization of the mode of inhibition and the basis of its specificity. Immunity
36: 239–250.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3299805</ArticleId>
            <ArticleId IdType="pubmed">22342841</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bettelli E, Korn T, Kuchroo VK. 2007. 
Th17: The third member of the effector T cell trilogy. Curr Opin Immunol
19: 652–657.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2288775</ArticleId>
            <ArticleId IdType="pubmed">17766098</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bouamar H, Jiang DF, Wang L, Lin AP, Ortega M, Aguiar RCT. 2015. 
MicroRNA 155 control of p53 activity is context dependent and mediated by Aicda and Socs1. Mol Cell Biol
35: 1329–1340.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4372698</ArticleId>
            <ArticleId IdType="pubmed">25645925</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bourdonnay E, Zaslona Z, Penke LRK, Speth JM, Schneider DJ, Przybranowski S, Swanson JA, Mancuso P, Freeman CM, Curtis JL, et al.
2015. 
Transcellular delivery of vesicular SOCS proteins from macrophages to epithelial cells blunts inflammatory signaling. J Exp Med
212: 729–742.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4419346</ArticleId>
            <ArticleId IdType="pubmed">25847945</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Catlett IM, Hedrick SM. 2005. 
Suppressor of cytokine signaling 1 is required for the differentiation of CD4+ T cells. Nat Immunol
6: 715–721.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15924143</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chambers JC, Loh M, Lehne B, Drong A, Kriebel J, Motta V, Wahl S, Elliott HR, Rota F, Scott WR, et al.
2015. 
Epigenome-wide association of DNA methylation markers in peripheral blood from Indian Asians and Europeans with incident type 2 diabetes: A nested case-control study. Lancet Diabetes Endo
3: 526–534.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4724884</ArticleId>
            <ArticleId IdType="pubmed">26095709</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chang JH, Xiao YC, Hu HB, Jin J, Yu JY, Zhou XF, Wu XF, Johnson HM, Akira SZ, Pasparakis M, et al.
2012. 
Ubc13 maintains the suppressive function of regulatory T cells and prevents their conversion into effector-like T cells. Nat Immunol
13: 481–U484.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3361639</ArticleId>
            <ArticleId IdType="pubmed">22484734</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chen S, Anderson PO, Li L, Sjogren HO, Wang P, Li SL. 2003. 
Functional association of cytokine-induced SH2 protein and protein kinase C in activated T cells. Int Immunol
15: 403–409.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12618484</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chen Z, Laurence A, Kanno Y, Pacher-Zavisin M, Zhu BM, Tato C, Yoshimura A, Hennighausen L, O’Shea JJ. 2006. 
Selective regulatory function of Socs3 in the formation of IL-17-secreting T cells. Proc Natl Acad Sci
103: 8137–8142.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1459629</ArticleId>
            <ArticleId IdType="pubmed">16698929</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chen SQ, Wang L, Fan J, Ye C, Dominguez D, Zhang Y, Curiel TJ, Fang DY, Kuzel TM, Zhang B. 2015. 
Host miR155 promotes tumor growth through a myeloid-derived suppressor cell-dependent mechanism. Cancer Res
75: 519–531.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4315710</ArticleId>
            <ArticleId IdType="pubmed">25502838</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chikuma S, Kanamori M, Mise-Omata S, Yoshimura A. 2017. 
Suppressors of cytokine signaling: Potential immune checkpoint molecules for cancerimmunotherapy. Cancer Sci
108: 574–580.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5406529</ArticleId>
            <ArticleId IdType="pubmed">28188673</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Choi YB, Son M, Park M, Shin J, Yun Y. 2010. 
SOCS-6 negatively regulates T cell activation through targeting p56(lck) to proteasomal degradation. J Biol Chem
285: 7271–7280.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2844175</ArticleId>
            <ArticleId IdType="pubmed">20007709</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>de Lapuente AL, Pinto-Medel MJ, Astobiza I, Alloza I, Comabella M, Malhotra S, Montalban X, Zettl UK, Rodriguez-Antiguedad A, Fernandez O, et al.
2015. 
Cell-specific effects in different immune subsets associated with SOCS1 genotypes in multiple sclerosis. Mult Scler
21: 1498–1512.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25623250</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Delconte RB, Kolesnik TB, Dagley LF, Rautela J, Shi W, Putz EM, Stannard K, Zhang JG, Teh C, Firth M, et al.
2016. 
CIS is a potent checkpoint in NK cell-mediated tumor immunity. Nat Immunol
17: 816.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27213690</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Disanto G, Sandve GK, Ricigliano VAG, Pakpoor J, Berlanga-Taylor AJ, Handel AE, Kuhle J, Holden L, Watson CT, Giovannoni G, et al.
2014. 
DNase hypersensitive sites and association with multiple sclerosis. Hum Mol Genet
23: 942–948.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24092328</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dong M, Li JX, Tang RQ, Zhu P, Qiu F, Wang C, Qiu J, Wang L, Dai YP, Xu P, et al.
2015. 
Multiple genetic variants associated with primary biliary cirrhosis in a Han Chinese population. Clin Rev Allerg Immunol
48: 316–321.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5584624</ArticleId>
            <ArticleId IdType="pubmed">25690649</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dubois PCA, Trynka G, Franke L, Hunt KA, Romanos J, Curtotti A, Zhernakova A, Heap GAR, Adany R, Aromaa A, et al.
2010. 
Multiple common variants for celiac disease influencing immune gene expression. Nat Genet
42: 295–302.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2847618</ArticleId>
            <ArticleId IdType="pubmed">20190752</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dudda JC, Salaun B, Ji Y, Palmer DC, Monnot GC, Merck E, Boudousquie C, Utzschneider DT, Escobar TM, Perret R, et al.
2013. 
MicroRNA-155 is required for effector CD8+ T cell responses to virus infection and cancer. Immunity
38: 742–753.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3788592</ArticleId>
            <ArticleId IdType="pubmed">23601686</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ellinghaus D, Ellinghaus E, Nair RP, Stuart PE, Esko T, Metspalu A, Debrus S, Raelson JV, Tejasvi T, Belouchi M, et al.
2012. 
Combined analysis of genome-wide association studies for Crohn disease and psoriasis identifies seven shared susceptibility loci. Am J Hum Genet
90: 636–647.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3322238</ArticleId>
            <ArticleId IdType="pubmed">22482804</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Endo TA, Masuhara M, Yokouchi M, Suzuki R, Sakamoto H, Mitsui K, Matsumoto A, Tanimura S, Ohtsubo M, Misawa H, et al.
1997. 
A new protein containing an SH2 domain that inhibits JAK kinases. Nature
387: 921–924.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9202126</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Endo T, Sasaki A, Minoguchi M, Joo A, Yoshimura A. 2003. 
CIS1 interacts with the Y532 of the prolactin receptor and suppresses prolactin-dependent STAT5 activation. J Biochem
133: 109–113.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12761205</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Feng Y, Arvey A, Chinen T, van der Veeken J, Gasteiger G, Rudensky AY. 2014. 
Control of the inheritance of regulatory T cell identity by a cis element in the Foxp3 locus. Cell
158: 749–763.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4151558</ArticleId>
            <ArticleId IdType="pubmed">25126783</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gagnon J, Ramanathan S, Leblanc C, Ilangumaran S. 2007. 
Regulation of IL-21 signaling by suppressor of cytokine signaling-1 (SOCS1) in CD8+ T lymphocytes. Cell Signal
19: 806–816.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17126530</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Greenhalgh CJ, Metcalf D, Thaus AL, Corbin JE, Uren R, Morgan PO, Fabri LJ, Zhang JG, Martin HM, Willson TA, et al.
2002. 
Biological evidence that SOCS-2 can act either as an enhancer or suppressor of growth hormone signaling. J Biol Chem
277: 40181–40184.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12208853</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Grigoryev DN, Cheranova DI, Chaudhary S, Heruth DP, Zhang LQ, Ye SQ. 2015. 
Identification of new biomarkers for acute respiratory distress syndrome by expression-based genome-wide association study. BMC Pulm Med
15: 95.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4545360</ArticleId>
            <ArticleId IdType="pubmed">26285698</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gui Y, Yeganeh M, Donates YC, Tobelaim WS, Chababi W, Mayhue M, Yoshimura A, Ramanathan S, Saucier C, Ilangumaran S. 2015. 
Regulation of MET receptor tyrosine kinase signaling by suppressor of cytokine signaling 1 in hepatocellular carcinoma. Oncogene
34: 5718–5728.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25728680</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Guschin D, Rogers N, Briscoe J, Witthuhn B, Watling D, Horn F, Pellegrini S, Yasukawa K, Heinrich P, Stark GR, et al.
1995. 
A major role for the protein tyrosine kinase JAK1 in the JAK/STAT signal transduction pathway in response to interleukin-6. EMBO J
14: 1421–1429.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC398228</ArticleId>
            <ArticleId IdType="pubmed">7537214</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hanada T, Yoshida T, Kinjyo I, Minoguchi S, Yasukawa H, Kato S, Mimata H, Nomura Y, Seki Y, Kubo M, et al.
2001. 
A mutant form of JAB/SOCS1 augments the cytokine-induced JAK/STAT pathway by accelerating degradation of wild-type JAB/CIS family proteins through the SOCS-box. J Biol Chem
276: 40746–40754.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11522790</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hanada T, Tanaka K, Matsumura Y, Yamauchi M, Nishinakamura H, Aburatani H, Mashima R, Kubo M, Kobayashi T, Yoshimura A. 2005. 
Induction of hyper Th1 cell-type immune responses by dendritic cells lacking the suppressor of cytokine signaling-1 gene. J Immunol
174: 4325–4332.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15778397</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hanada T, Kobayashi T, Chinen T, Saeki K, Takaki H, Koga K, Minoda Y, Sanada T, Yoshioka T, Mimata H, et al.
2006. 
IFNγ-dependent, spontaneous development of colorectal carcinomas in SOCS1-deficient mice. J Exp Med
203: 1391–1397.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2118311</ArticleId>
            <ArticleId IdType="pubmed">16717119</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hao K, Bosse Y, Nickle DC, Pare PD, Postma DS, Laviolette M, Sandford A, Hackett TL, Daley D, Hogg JC, et al.
2012. 
Lung eQTLs to help reveal the molecular underpinnings of asthma. PloS Genet
8: e1003029.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3510026</ArticleId>
            <ArticleId IdType="pubmed">23209423</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hashimoto M, Ayada T, Kinjyo I, Hiwatashi K, Yoshida H, Okada Y, Kobayashi T, Yoshimura A. 2009. 
Silencing of SOCS1 in macrophages suppresses tumor development by enhancing antitumor inflammation. Cancer Sci
100: 730–736.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19469017</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hilton DJ, Richardson RT, Alexander WS, Viney EM, Willson TA, Sprigg NS, Starr R, Nicholson SE, Metcalf D, Nicola NA. 1998. 
Twenty proteins containing a C-terminal SOCS box form five structural classes. Proc Natl Acad Sci
95: 114–119.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC18144</ArticleId>
            <ArticleId IdType="pubmed">9419338</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hirata Y, Brems H, Suzuki M, Kanamori M, Okada M, Morita R, Llano-Rivas I, Ose T, Messiaen L, Legius E, et al.
2016. 
Interaction between a domain of the negative regulator of the Ras-ERK pathway, SPRED1 protein, and the GTPase-activating protein-related domain of neurofibromin is implicated in Legius syndrome and neurofibromatosis type 1. J Biol Chem
291: 3124–3134.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4751360</ArticleId>
            <ArticleId IdType="pubmed">26635368</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hu Z, Yang J, Wu Y, Xiong G, Wang Y, Yang J, Deng L. 2014. 
Polymorphisms in CISH gene are associated with persistent hepatitis B virus infection in Han Chinese population. PloS ONE
9: e100826.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4071005</ArticleId>
            <ArticleId IdType="pubmed">24964072</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Inagaki-Ohara K, Kondo T, Ito M, Yoshimura A. 2013. 
SOCS, inflammation, and cancer. JAKSTAT
2: e24053.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3772102</ArticleId>
            <ArticleId IdType="pubmed">24069550</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Inagaki-Ohara K, Mayuzumi H, Kato S, Minokoshi Y, Otsubo T, Kawamura YI, Dohi T, Matsuzaki G, Yoshimura A. 2014. 
Enhancement of leptin receptor signaling by SOCS3 deficiency induces development of gastric tumors in mice. Oncogene
33: 74–84.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23178499</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jenkins BJ, Grail D, Nheu T, Najdovska M, Wang B, Waring P, Inglese M, McLoughlin RM, Jones SA, Topley N, et al.
2005. 
Hyperactivation of Stat3 in gp130 mutant mice promotes gastric hyperproliferation and desensitizes TGF-β signaling. Nat Med
11: 845–852.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16041381</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Judd LM, Bredin K, Kalantzis A, Jenkins BJ, Ernst M, Giraud AS. 2006. 
STAT3 activation regulates growth, inflammation, and vascularization in a mouse model of gastric tumorigenesis. Gastroenterology
131: 1073–1085.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17030178</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kamio M, Yoshida T, Ogata H, Douchi T, Nagata Y, Inoue M, Hasegawa M, Yonemitsu Y, Yoshimura A. 2004. 
SOC1 inhibits HPV-E7-mediated transformation by inducing degradation of E7 protein. Oncogene
23: 3107–3115.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15021916</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kamizono S, Hanada T, Yasukawa H, Minoguchi S, Kato R, Minoguchi M, Hattori K, Hatakeyama S, Yada M, Morita S, et al.
2001. 
The SOCS box of SOCS-1 accelerates ubiquitin-dependent proteolysis of TEL-JAK2. J Biol Chem
276: 12530–12538.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11278610</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kamura T, Maenaka K, Kotoshiba S, Matsumoto M, Kohda D, Conaway RC, Conaway JW, Nakayama KI. 2004. 
VHL-box and SOCS-box domains determine binding specificity for Cul2-Rbx1 and Cul5-Rbx2 modules of ubiquitin ligases. Genes Dev
18: 3055–3065.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC535916</ArticleId>
            <ArticleId IdType="pubmed">15601820</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Karabulut R, Turkyilmaz Z, Sonmez K, Kumas G, Ergun SG, Ergun MA, Basaklar AC. 2013. 
Twenty-four genes are upregulated in patients with hypospadias. J Med Genet
16: 39–43.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4001414</ArticleId>
            <ArticleId IdType="pubmed">24778562</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kershaw NJ, Murphy JM, Liau NP, Varghese LN, Laktyushin A, Whitlock EL, Lucet IS, Nicola NA, Babon JJ. 2013. 
SOCS3 binds specific receptor-JAK complexes to control cytokine signaling by direct kinase inhibition. Nat Struct Mol Biol
20: 469–476.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3618588</ArticleId>
            <ArticleId IdType="pubmed">23454976</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Khor CC, Vannberg FO, Chapman SJ, Guo H, Wong SH, Walley AJ, Vukcevic D, Rautanen A, Mills TC, Chang KC, et al.
2010. 
CISH and susceptibility to infectious diseases. N Engl J Med
362: 2092–2101.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3646238</ArticleId>
            <ArticleId IdType="pubmed">20484391</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kinjyo I, Inoue H, Hamano S, Fukuyama S, Yoshimura T, Koga K, Takaki H, Himeno K, Takaesu G, Kobayashi T, et al.
2006. 
Loss of SOCS3 in T helper cells resulted in reduced immune responses and hyperproduction of interleukin 10 and transforming growth factor-β1. J Exp Med
203: 1021–1031.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2118269</ArticleId>
            <ArticleId IdType="pubmed">16606674</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lan F, Zhang N, Zhang J, Krysko O, Zhang QB, Xian JM, Derycke L, Qi YY, Li K, Liu SX, et al.
2013. 
Forkhead box protein 3 in human nasal polyp regulatory T cells is regulated by the protein suppressor of cytokine signaling 3. J Allergy Clin Immun
132: 1314.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23910692</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Le Y, Zhu BM, Harley B, Park SY, Kobayashi T, Manis JP, Luo HR, Yoshimura A, Hennighausen L, Silberstein LE. 2007. 
SOCS3 protein developmentally regulates the chemokine receptor CXCR4-FAK signaling pathway during B lymphopoiesis. Immunity
27: 811–823.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18031698</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lee SH, Yun S, Piao ZH, Jeong M, Kim DO, Jung H, Lee J, Kim MJ, Kim MS, Chung JW, et al.
2010. 
Suppressor of cytokine signaling 2 regulates IL-15-primed human NK cell function via control of phosphorylated Pyk2. J Immunol
185: 917–928.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20543098</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Leikfoss IS, Keshari PK, Gustavsen MW, Bjolgerud A, Brorson IS, Celius EG, Spurkland A, Bos SD, Harbo HF, Berge T. 2015. 
Multiple sclerosis risk allele in CLEC16A acts as an expression quantitative trait locus for CLEC16A and SOCS1 in CD4+ T cells. PloS ONE
10: e0132957.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4512731</ArticleId>
            <ArticleId IdType="pubmed">26203907</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lennerz JK, Hoffmann K, Bubolz AM, Lessel D, Welke C, Ruther N, Viardot A, Moller P. 2015. 
Suppressor of cytokine signaling 1 gene mutation status as a prognostic biomarker in classical Hodgkin lymphoma. Oncotarget
6: 29097–29110.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4745714</ArticleId>
            <ArticleId IdType="pubmed">26336985</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lesina M, Kurkowski MU, Ludes K, Rose-John S, Treiber M, Kloppel G, Yoshimura A, Reindl W, Sipos B, Akira S, et al.
2011. 
Stat3/Socs3 activation by IL-6 transsignaling promotes progression of pancreatic intraepithelial neoplasia and development of pancreatic cancer. Cancer Cell
19: 456–469.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21481788</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lewis RS, Noor SM, Fraser FW, Sertori R, Liongue C, Ward AC. 2014. 
Regulation of embryonic hematopoiesis by a cytokine-inducible SH2 domain homolog in zebrafish. J Immunol
92: 5739–5748.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24835394</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Li S, Chen S, Xu X, Sundstedt A, Paulsson KM, Anderson P, Karlsson S, Sjogren HO, Wang P. 2000. 
Cytokine-induced Src homology 2 protein (CIS) promotes T cell receptor-mediated proliferation and prolongs survival of activated T cells. J Exp Med
191: 985–994.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2193118</ArticleId>
            <ArticleId IdType="pubmed">10727460</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Liu H, Irwanto A, Fu X, Yu GQ, Yu YX, Sun YH, Wang C, Wang ZZ, Okada Y, Low HQ, et al.
2015. 
Discovery of six new susceptibility loci and analysis of pleiotropic effects in leprosy. Nat Genet
47: 267.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25642632</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lu LF, Thai TH, Calado DP, Chaudhry A, Kubo M, Tanaka K, Loeb GB, Lee H, Yoshimura A, Rajewsky K, et al.
2009. 
Foxp3-dependent microRNA155 confers competitive fitness to regulatory T cells by targeting SOCS1 protein. Immunity
30: 80–91.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2654249</ArticleId>
            <ArticleId IdType="pubmed">19144316</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lu LF, Boldin MP, Chaudhry A, Lin LL, Taganov KD, Hanada T, Yoshimura A, Baltimore D, Rudensky AY. 2010. 
Function of miR-146a in controlling Treg cell-mediated regulation of Th1 responses. Cell
142: 914–929.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3049116</ArticleId>
            <ArticleId IdType="pubmed">20850013</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lu LF, Gasteiger G, Yu IS, Chaudhry A, Hsin JP, Lu YH, Bos PD, Lin LL, Zawislak CL, Cho SL, et al.
2015. 
A single miRNA-mRNA interaction affects the immune response in a context- and cell-type-specific manner. Immunity
43: 52–64.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4529747</ArticleId>
            <ArticleId IdType="pubmed">26163372</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Luckey MA, Kimura MY, Waickman AT, Feigenbaum L, Singer A, Park JH. 2014. 
The transcription factor ThPOK suppresses Runx3 and imposes CD4+ lineage fate by inducing the SOCS suppressors of cytokine signaling. Nat Immunol
15: 638–645.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6693509</ArticleId>
            <ArticleId IdType="pubmed">24880459</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mallette FA, Calabrese V, Ilangumaran S, Ferbeyre G. 2010. 
SOCS1, a novel interaction partner of p53 controlling oncogene-induced senescence. Aging (Albany NY)
2: 445–452.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2933891</ArticleId>
            <ArticleId IdType="pubmed">20622265</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mansell A, Smith R, Doyle SL, Gray P, Fenner JE, Crack PJ, Nicholson SE, Hilton DJ, O’Neill LA, Hertzog PJ. 2006. 
Suppressor of cytokine signaling 1 negatively regulates Toll-like receptor signaling by mediating Mal degradation. Nat Immunol
7: 148–155.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16415872</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Matsumoto A, Masuhara M, Mitsui K, Yokouchi M, Ohtsubo M, Misawa H, Miyajima A, Yoshimura A. 1997. 
CIS, a cytokine inducible SH2 protein, is a target of the JAK-STAT5 pathway and modulates STAT5 activation. Blood
89: 3148–3154.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9129017</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Matsumura Y, Kobayashi T, Ichiyama K, Yoshida R, Hashimoto M, Takimoto T, Tanaka K, Chinen T, Shichita T, Wyss-Coray T, et al.
2007. 
Selective expansion of Foxp3-positive regulatory T cells and immunosuppression by suppressors of cytokine signaling 3-deficient dendritic cells. J Immunol
179: 2170–2179.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17675476</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mostecki J, Cassel SL, Klimecki WT, Stern DA, Knisz J, Iwashita S, Graves P, Miller RL, van Peer M, Halonen M, et al.
2011. 
A SOCS-1 promoter variant is associated with total serum IgE levels. J Immunol
187: 2794–2802.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3159751</ArticleId>
            <ArticleId IdType="pubmed">21795592</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nonami A, Kato R, Harada M, Yoshimura A. 2003. 
Spred-1 negatively regulates cytokine-induced MAP kinase activation in hematopoietic cells. Blood
102: 833A–833A.</Citation>
        </Reference>
        <Reference>
          <Citation>Ogata H, Kobayashi T, Chinen T, Takaki H, Sanada T, Minoda Y, Koga K, Takaesu G, Maehara Y, Iida M, et al.
2006. 
Deletion of the SOCS3 gene in liver parenchymal cells promotes hepatitis-induced hepatocarcinogenesis. Gastroenterology
131: 179–193.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16831601</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Okabe S, Tauchi T, Morita H, Ohashi H, Yoshimura A, Ohyashiki K. 1999. 
Thrombopoietin induces an SH2-containing protein, CIS1, which binds to Mpl: Involvement of the ubiquitin proteosome pathway. Exp Hematol
27: 1542–1547.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10517496</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>O’Shea JJ, Gadina M, Schreiber RD. 2002. 
Cytokine signaling in 2002: New surprises in the Jak/Stat pathway. Cell
109: S121–S131.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11983158</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Palmer DC, Guittard GC, Franco Z, Crompton JG, Eil RL, Patel SJ, Ji Y, Van Panhuys N, Klebanoff CA, Sukumar M, et al.
2015. 
Cish actively silences TCR signaling in CD8+ T cells to maintain tumor tolerance. J Exp Med
212: 2095–2113.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4647263</ArticleId>
            <ArticleId IdType="pubmed">26527801</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ram PA, Waxman DJ. 2000. 
Role of the cytokine-inducible SH2 protein CIS in desensitization of STAT5b signaling by continuous growth hormone. J Biol Chem
275: 39487–39496.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10991939</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ramanathan S, Dubois S, Gagnon J, Leblanc C, Mariathasan S, Ferbeyre G, Rottapel R, Ohashi PS, Ilangumaran S. 2010. 
Regulation of cytokine-driven functional differentiation of CD8 T cells by suppressor of cytokine signaling 1 controls autoimmunity and preserves their proliferative capacity toward foreign antigens. J Immunol
185: 357–366.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20519645</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Romain M, Taleb S, Dalloz M, Ponnuswamy P, Esposito B, Perez N, Wang Y, Yoshimura A, Tedgui A, Mallat Z. 2013. 
Overexpression of SOCS3 in T lymphocytes leads to impaired interleukin-17 production and severe aortic aneurysm formation in mice-brief report. Arterioscler Thromb Vasc Biol
33: 581–584.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23329138</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Schif B, Lennerz JK, Kohler CW, Bentink S, Kreuz M, Melzner I, Ritz O, Trumper L, Loeffler M, Spang R, et al.
2013. 
SOCS1 mutation subtypes predict divergent outcomes in diffuse large B-cell lymphoma (DLBCL) patients. Oncotarget
4: 35–47.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3702206</ArticleId>
            <ArticleId IdType="pubmed">23296022</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Seki Y, Inoue H, Nagata N, Hayashi K, Fukuyama S, Matsumoto K, Komine O, Hamano S, Himeno K, Inagaki-Ohara K, et al.
2003. 
SOCS-3 regulates onset and maintenance of TH2-mediated allergic responses. Nat Med
9: 1047–1054.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12847520</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sekiya T, Nakatsukasa H, Lu Q, Yoshimura A. 2016. 
Roles of transcription factors and epigenetic modifications in differentiation and maintenance of regulatory T cells. Microbes Infect
18: 378–386.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26970203</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sharma M, Mitnala S, Vishnubhotla RK, Mukherjee R, Reddy DN, Rao PN. 2015. 
The riddle of nonalcoholic fatty liver disease: Progression from nonalcoholic fatty liver to nonalcoholic steatohepatitis. J Clin Exp Hepatol
5: 147–158.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4491606</ArticleId>
            <ArticleId IdType="pubmed">26155043</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shembade N, Harhaj EW. 2012. 
Regulation of NF-κB signaling by the A20 deubiquitinase. Cell Mol Immunol
9: 123–130.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3532050</ArticleId>
            <ArticleId IdType="pubmed">22343828</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shen L, Evel-Kabler K, Strube R, Chen SY. 2004. 
Silencing of SOCS1 enhances antigen presentation by dendritic cells and antigen-specific anti-tumor immunity. Nat Biotechnol
22: 1546–1553.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15558048</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shi H, Tzameli I, Bjorbaek C, Flier JS. 2004. 
Suppressor of cytokine signaling 3 is a physiological regulator of adipocyte insulin signaling. J Biol Chem
279: 34733–34740.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15181014</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shouda T, Yoshida T, Hanada T, Wakioka T, Oishi M, Miyoshi K, Komiya S, Kosai K, Hanakawa Y, Hashimoto K, et al.
2001. 
Induction of the cytokine signal regulator SOCS3/CIS3 as a therapeutic strategy for treating inflammatory arthritis. J Clin Invest
108: 1781–1788.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC209467</ArticleId>
            <ArticleId IdType="pubmed">11748261</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shouda T, Hiraoka K, Komiya S, Hamada T, Zenmyo M, Iwasaki H, Isayama T, Fukushima N, Nagata K, Yoshimura A. 2006. 
Suppression of IL-6 production and proliferation by blocking STAT3 activation in malignant soft tissue tumor cells. Cancer Lett
231: 176–184.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16399222</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Song G, Rao H, Feng B, Wei L. 2014. 
Association between CISH polymorphisms and spontaneous clearance of hepatitis B virus in hepatitis B extracellular antigen-positive patients during immune active phase. Chin Med J (Engl)
127: 1691–1695.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24791876</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Suessmuth Y, Elliott J, Percy MJ, Inami M, Attal H, Harrison CN, Inokuchi K, McMullin MF, Johnston JA. 2009. 
A new polycythaemia vera-associated SOCS3 SH2 mutant (SOCS3F136L) cannot regulate erythropoietin responses. Brit J Haematol
147: 450–458.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2838228</ArticleId>
            <ArticleId IdType="pubmed">19735488</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sun R, Jaruga B, Kulkarni S, Sun HY, Gao B. 2005. 
IL-6 modulates hepatocyte proliferation via induction of HGF/p21cip1: Regulation by SOCS3. Biochem Biophys Res Commun
338: 1943–1949.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16288983</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sun L, Jin YQ, Shen C, Qi H, Chu P, Yin QQ, Li JQ, Tian JL, Jiao WW, Xiao J, et al.
2014. 
Genetic contribution of CISH promoter polymorphisms to susceptibility to tuberculosis in Chinese children. PloS ONE
9: e92020.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3954833</ArticleId>
            <ArticleId IdType="pubmed">24632804</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tagami-Nagata N, Serada S, Fujimoto M, Tanemura A, Nakatsuka R, Ohkawara T, Murota H, Kishimoto T, Katayama I, Naka T. 2015. 
Suppressor of cytokine signalling-1 induces significant preclinical antitumor effect in malignant melanoma cells. Exp Dermatol
24: 864–871.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26173926</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Takahashi R, Yoshimura A. 2014. 
SOCS1 and regulation of regulatory T cells plasticity. J Immunol Res
2014: 943149.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4123481</ArticleId>
            <ArticleId IdType="pubmed">25133199</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Takahashi R, Nishimoto S, Muto G, Sekiya T, Tamiya T, Kimura A, Morita R, Asakawa M, Chinen T, Yoshimura A. 2011. 
SOCS1 is essential for regulatory T cell functions by preventing loss of Foxp3 expression as well as IFN-γ and IL-17A production. J Exp Med
208: 2055–2067.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3182063</ArticleId>
            <ArticleId IdType="pubmed">21893603</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Takimoto T, Wakabayashi Y, Sekiya T, Inoue N, Morita R, Ichiyama K, Takahashi R, Asakawa M, Muto G, Mori T, et al.
2010. 
Smad2 and Smad3 are redundantly essential for the TGF-β-mediated regulation of regulatory T plasticity and Th1 development. J Immunol
185: 842–855.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20548029</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Taleb S, Romain M, Ramkhelawon B, Uyttenhove C, Pasterkamp G, Herbin O, Esposito B, Perez N, Yasukawa H, Van Snick J, et al.
2009. 
Loss of SOCS3 expression in T cells reveals a regulatory role for interleukin-17 in atherosclerosis. J Exp Med
206: 2067–2077.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2757872</ArticleId>
            <ArticleId IdType="pubmed">19737863</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tamiya T, Kashiwagi I, Takahashi R, Yasukawa H, Yoshimura A. 2011. 
Suppressors of cytokine signaling (SOCS) proteins and JAK/STAT pathways: Regulation of T-cell inflammation by SOCS1 and SOCS3. Arterioscler Thromb Vasc Biol
31: 980–985.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21508344</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tamiya T, Ichiyama K, Kotani H, Fukaya T, Sekiya T, Shichita T, Honma K, Yui K, Matsuyama T, Nakao T, et al.
2013. 
Smad2/3 and IRF4 play a cooperative role in IL-9-producing T cell induction. J Immunol
191: 2360–2371.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23913959</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tanaka K, Ichiyama K, Hashimoto M, Yoshida H, Takimoto T, Takaesu G, Torisu T, Hanada T, Yasukawa H, Fukuyama S, et al.
2008. 
Loss of suppressor of cytokine signaling 1 in helper T cells leads to defective Th17 differentiation by enhancing antagonistic effects of IFN-γ on STAT3 and Smads. J Immunol
180: 3746–3756.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18322180</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tang B, Wang ZR, Qi GY, Yuan SG, Yu SP, Li B, Wei YC, Huang Q, Zhai R, He SQ. 2015. 
MicroRNA-155 deficiency attenuates ischemia-reperfusion injury after liver transplantation in mice. Transpl Int
28: 751–760.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25611689</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tokumaru S, Sayama K, Yamasaki K, Shirakata Y, Hanakawa Y, Yahata Y, Dai XJ, Tohyama M, Yang LJ, Yoshimura A, et al.
2005. 
SOCS3/CIS3 negative regulation of STAT3 in HGF-induced keratinocyte migration. Biochem Biophys Res Commun
327: 100–105.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15629435</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tong HV, Toan NL, Song le H, Kremsner PG, Kun JF, Tp V. 2012. 
Association of CISH -292A/T genetic variant with hepatitis B virus infection. Immunogenetics
64: 261–265.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22033525</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Torisu T, Sato N, Yoshiga D, Kobayashi T, Yoshioka T, Mori H, Iida M, Yoshimura A. 2007. 
The dual function of hepatic SOCS3 in insulin resistance in vivo. Genes Cells
12: 143–154.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17295835</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Vogelzang A, McGuire HM, Yu D, Sprent J, Mackay CR, King C. 2008. 
A fundamental role for interleukin-21 in the generation of T follicular helper cells. Immunity
29: 127–137.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18602282</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wakioka T, Sasaki A, Kato R, Shouda T, Matsumoto A, Miyoshi K, Tsuneoka M, Komiya S, Baron R, Yoshimura A. 2001. 
Spred is a Sprouty-related suppressor of Ras signalling. Nature
412: 647–651.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11493923</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang X, Li T, Li M, Cao N, Han J. 2016. 
The functional SOCS3 RS115785973 variant regulated by MiR-4308 promotes gastric cancer development in Chinese population. Cell Physiol Biochem
38: 1796–1802.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27160093</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Weber-Nordt RM, Riley JK, Greenlund AC, Moore KW, Darnell JE, Schreiber RD. 1996. 
Stat3 recruitment by two distinct ligand-induced, tyrosine-phosphorylated docking sites in the interleukin-10 receptor intracellular domain. J Biol Chem
271: 27954–27961.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">8910398</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yamamoto K, Yamaguchi M, Miyasaka N, Miura O. 2003. 
SOCS-3 inhibits IL-12-induced STAT4 activation by binding through its SH2 domain to the STAT4 docking site in the IL-12 receptor β2 subunit. Biochem Biophys Res Commun
310: 1188–1193.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">14559241</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yang XXO, Zhang HY, Kim BS, Niu XY, Peng J, Chen YH, Kerketta R, Lee YH, Chang SH, Corry DB, et al.
2013. 
The signaling suppressor CIS controls proallergic T cell development and allergic airway inflammation. Nat Immunol
14: 732.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4084713</ArticleId>
            <ArticleId IdType="pubmed">23727894</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yasukawa H, Misawa H, Sakamoto H, Masuhara M, Sasaki A, Wakioka T, Ohtsuka S, Imaizumi T, Matsuda T, Ihle JN, et al.
1999. 
The JAK-binding protein JAB inhibits Janus tyrosine kinase activity through binding in the activation loop. EMBO J
18: 1309–1320.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1171221</ArticleId>
            <ArticleId IdType="pubmed">10064597</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yasukawa H, Ohishi M, Mori H, Murakami M, Chinen T, Aki D, Hanada T, Takeda K, Akira S, Hoshijima M, et al.
2003. 
IL-6 induces an anti-inflammatory response in the absence of SOCS3 in macrophages. Nat Immunol
4: 551–556.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12754507</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yeganeh M, Gui Y, Kandhi R, Bobbala D, Tobelaim WS, Saucier C, Yoshimura A, Ferbeyre G, Ramanathan S, Ilangumaran S. 2016. 
Suppressor of cytokine signaling 1-dependent regulation of the expression and oncogenic functions of p21 in the liver. Oncogene
35: 4200–4211.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26725321</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yoshida T, Ogata H, Kamio M, Joo A, Shiraishi H, Tokunaga Y, Sata M, Nagai H, Yoshimura A. 2004. 
SOCS1 is a suppressor of liver fibrosis and hepatitis-induced carcinogenesis. J Exp Med
199: 1701–1707.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2212816</ArticleId>
            <ArticleId IdType="pubmed">15197228</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yoshida T, Hisamoto T, Akiba J, Koga H, Nakamura K, Tokunaga Y, Hanada S, Kumemura H, Maeyama M, Harada M, et al.
2006. 
Spreds, inhibitors of the Ras/ERK signal transduction, are dysregulated in human hepatocellular carcinoma and linked to the malignant phenotype of tumors. Oncogene
25: 6056–6066.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16652141</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yoshikawa H, Matsubara K, Qian GS, Jackson P, Groopman JD, Manning JE, Harris CC, Herman JG. 2001. 
SOCS-1, a negative regulator of the JAK/STAT pathway, is silenced by methylation in human hepatocellular carcinoma and shows growth-suppression activity. Nat Genet
28: 29–35.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11326271</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yoshimura A, Ohkubo T, Kiguchi T, Jenkins NA, Gilbert DJ, Copeland NG, Hara T, Miyajima A. 1995. 
A novel cytokine-inducible gene CIS encodes an SH2-containing protein that binds to tyrosine-phosphorylated interleukin 3 and erythropoietin receptors. EMBO J
14: 2816–2826.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC398400</ArticleId>
            <ArticleId IdType="pubmed">7796808</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yoshimura A, Naka T, Kubo M. 2007. 
SOCS proteins, cytokine signalling and immune regulation. Nat Rev Immunol
7: 454–465.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17525754</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yoshimura A, Suzuki M, Sakaguchi R, Hanada T, Yasukawa H. 2012. 
SOCS, inflammation, and autoimmunity. Front Immunol
3: 20.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3342034</ArticleId>
            <ArticleId IdType="pubmed">22566904</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
